NxStage Announces Third Quarter 2011 Investor Conference Schedule
LAWRENCE, Mass., Aug 5, 2011 /PRNewswire via COMTEX/ —
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and Robert Brown, Chief Financial Officer, will participate in the following schedule of investor conferences. A webcast of the event will be made available at https://www.nxstage.com/ir.cfm at the time of each conference.
(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )
| Lazard Capital Markets 2nd Annual Medical Technology Corporate Access Day | |
| Peninsula Hotel, Chicago, IL | |
| Tuesday, Aug. 9, 2011 | |
| 2011 Canaccord Genuity Growth Conference | |
| Wednesday, Aug. 10, 2011 | |
| Rodman & Renshaw Annual Global Investment Conference | |
| The Waldorf-Astoria, New York, NY | |
| September 11-13, 2011 | |
| Jefferies 2011 Global Healthcare Conference | |
| The Waldorf Hilton, London, UK | |
| September 27-28, 2011 | |
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company’s website at https://www.nxstage.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words anticipate, believe, expect, estimate, plan, and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Messrs. Burbank and Brown’s plans to present at these conferences. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage’s expectations or beliefs as of any date subsequent to the date of this press release.
Contact:
Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com
SOURCE NxStage Medical, Inc.
